đź’Š
Healthcare
Roche Pharmaceuticals
Accelerating Drug Discovery with Quantum Molecular Simulation
The Challenge
Traditional drug discovery takes 10-15 years and costs billions. Molecular simulation on classical computers is limited by the exponential scaling of quantum mechanical interactions.
The Solution
Q-Intercept deployed quantum algorithms for molecular dynamics simulation, protein folding prediction, and drug-target interaction modeling, reducing discovery time by orders of magnitude.
Implementation Journey
1
Phase 1: Target Identification
4 months
Quantum algorithms for protein structure prediction
2
Phase 2: Lead Optimization
8 months
Quantum simulation of drug-protein interactions
3
Phase 3: Clinical Integration
6 months
Integration with existing drug discovery pipeline
Measurable Impact
60%
reduction in lead identification
Discovery Time
3.5x
higher hit rate for drug candidates
Success Rate
$450M
saved in R&D costs annually
Cost Savings
12
new drug candidates identified
Candidates
Quantum Technologies Used
VQE
Quantum ML
Protein Folding Algorithms
Molecular Dynamics
"
Quantum computing is not just the future of drug discovery—it's the present. Q-Intercept made it accessible to our research teams.
Dr. Sarah Chen
Chief Scientific Officer, Roche